These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38758868)

  • 1. Can the use of antithrombotic drugs be a predictive factor in the early diagnosis of bladder cancer?: A single-center analysis.
    Ekici M; Demir E; Aydin C; Çağlayan MS; Özgür BC; Baykam MM
    Medicine (Baltimore); 2024 May; 103(20):e38228. PubMed ID: 38758868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Effect of Antiplatelet and Anticoagulant Therapy on the Timing of the Diagnosis of Bladder Cancer.
    Moschini M; Karnes RJ; Suardi N; Bianchi M; Pellucchi F; Rocchini L; Damiano R; Serretta V; Salonia A; Montorsi F; Briganti A; Colombo R
    Clin Genitourin Cancer; 2016 Jun; 14(3):e245-50. PubMed ID: 26382220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HOXA9, PCDH17, POU4F2, and ONECUT2 as a Urinary Biomarker Combination for the Detection of Bladder Cancer in Chinese Patients with Hematuria.
    Wu Y; Jiang G; Zhang N; Liu S; Lin X; Perschon C; Zheng SL; Ding Q; Wang X; Na R; Sun J; Xu J
    Eur Urol Focus; 2020 Mar; 6(2):284-291. PubMed ID: 30309818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microscopic haematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer.
    Ramirez D; Gupta A; Canter D; Harrow B; Dobbs RW; Kucherov V; Mueller E; Streeper N; Uhlman MA; Svatek RS; Messing EM; Lotan Y
    BJU Int; 2016 May; 117(5):783-6. PubMed ID: 26435378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newly diagnosed bladder cancer: the relationship of initial symptoms, degree of microhematuria and tumor marker status.
    Boman H; Hedelin H; Jacobsson S; Holmäng S
    J Urol; 2002 Nov; 168(5):1955-9. PubMed ID: 12394684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of 2004 ISUP/WHO classification on bladder cancer grading.
    Lokeshwar SD; Ruiz-Cordero R; Hupe MC; Jorda M; Soloway MS
    World J Urol; 2015 Dec; 33(12):1929-36. PubMed ID: 25833661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of MCM5 (ADXBLADDER) analysis in urine of men evaluated for the initial diagnosis of bladder cancer: A comparative prospective study.
    Anastasi E; Maggi M; Tartaglione S; Angeloni A; Gennarini G; Leoncini PP; Sperduti I; Di Lascio G; De Stefano V; Di Pierro GB; Del Giudice F; Busetto GM; De Berardinis E; Sciarra A
    Diagn Cytopathol; 2020 Nov; 48(11):1034-1040. PubMed ID: 32562513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of superficial bladder cancer.
    Amling CL
    Curr Probl Cancer; 2001; 25(4):219-78. PubMed ID: 11514784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations.
    Messing EM; Young TB; Hunt VB; Gilchrist KW; Newton MA; Bram LL; Hisgen WJ; Greenberg EB; Kuglitsch ME; Wegenke JD
    Urology; 1995 Mar; 45(3):387-96; discussion 396-7. PubMed ID: 7879333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical predictors for high-grade bladder cancer before first-time transurethral resection of the bladder tumor: a retrospective cohort study.
    Wakai K; Utsumi T; Oka R; Endo T; Yano M; Kamijima S; Kamiya N; Hiruta N; Suzuki H
    Jpn J Clin Oncol; 2016 Oct; 46(10):964-967. PubMed ID: 27511986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The feasibility of multimodal fiber optic spectroscopy analysis in bladder cancer detection, grading, and staging.
    Morselli S; Baria E; Cicchi R; Liaci A; Sebastianelli A; Nesi G; Serni S; Pavone FS; Gacci M
    Urologia; 2021 Nov; 88(4):306-314. PubMed ID: 33789562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria.
    Kim WT; Jeong P; Yan C; Kim YH; Lee IS; Kang HW; Kim YJ; Lee SC; Kim SJ; Kim YT; Moon SK; Choi YH; Kim IY; Yun SJ; Kim WJ
    Oncotarget; 2016 Sep; 7(36):58193-58202. PubMed ID: 27528424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomics analysis of multiparametric MRI for the preoperative evaluation of pathological grade in bladder cancer tumors.
    Wang H; Hu D; Yao H; Chen M; Li S; Chen H; Luo J; Feng Y; Guo Y
    Eur Radiol; 2019 Nov; 29(11):6182-6190. PubMed ID: 31016445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outpatient diode laser treatment of intermediate-risk non-invasive bladder tumors without sedation: efficacy, safety and economic analysis.
    Hermann GG; Mogensen K; Rosthøj S
    Scand J Urol; 2018 Jun; 52(3):194-198. PubMed ID: 29607745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of antithrombotic therapy on the time of detection of bladder cancer.
    Jakus D; Šitum M; Čepin P; Vrhovac I; Borovac JA
    Cent European J Urol; 2023; 76(1):33-37. PubMed ID: 37064258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does antithrombotic use enable earlier diagnosis of bladder cancer? A brief institutional assessment.
    Shah YB; Clark CB; Shumaker A; Denisenko AA; Alfonsi S; Prebay Z; Schultz J; Mico V; Swaminathan V; Wang R; Mark JR; Trabulsi EJ; Lallas CD; Mann MJ; Goldberg H; Chandrasekar T
    Can J Urol; 2022 Dec; 29(6):11391-11393. PubMed ID: 36495582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of diffusion-weighted MRI of the bladder as a biomarker for prediction of bladder cancer aggressiveness.
    Sevcenco S; Ponhold L; Heinz-Peer G; Fajkovic H; Haitel A; Susani M; Shariat SF; Szarvas T; Baltzer PA
    Urol Oncol; 2014 Nov; 32(8):1166-71. PubMed ID: 24962659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of miR-100 as a novel ancillary non-invasive biomarker for early detection of bladder carcinoma.
    Qureshi A; Fahim A; Kazi N; Farsi Kazi SA; Nadeem F
    J Pak Med Assoc; 2018 May; 68(5):759-763. PubMed ID: 29885177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage T1 bladder cancer: grade is the primary determinant for risk of muscle invasion.
    Kaubisch S; Lum BL; Reese J; Freiha F; Torti FM
    J Urol; 1991 Jul; 146(1):28-31. PubMed ID: 2056599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does urinary cytology have a role in haematuria investigations?
    Tan WS; Sarpong R; Khetrapal P; Rodney S; Mostafid H; Cresswell J; Watson D; Rane A; Hicks J; Hellawell G; Davies M; Srirangam SJ; Dawson L; Payne D; Williams N; Brew-Graves C; Feber A; Kelly JD;
    BJU Int; 2019 Jan; 123(1):74-81. PubMed ID: 30003675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.